Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux

Molecular and Cellular Biology

Volumn 22, Issue 8, 2002, Pages 2607-2619

  Akiyama, Taro E ^a   Sakai, Shuichi ^a   Lambert, Gilles ^a   Nicol, Christopher J ^a   Matsusue, Kimihiko ^a   Pimprale, Satish ^a   Lee, Ying Hue ^a   Ricote, Mercedes ^a   Glass, Christopher K ^a   Brewer Jr , H Bryan ^a   Gonzalez, Frank J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ALPHA INTERFERON; APOLIPOPROTEIN E; BETA INTERFERON; CD36 ANTIGEN; CHOLESTEROL; CIGLITAZONE; CRE RECOMBINASE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROTEIN ABCG1; ROSIGLITAZONE; THIOGLYCOLIC ACID; TROGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DNA FLANKING REGION; EXON; GENE DISRUPTION; GENETIC TRANSCRIPTION; HOMEOSTASIS; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSPORT KINETICS;

ALLELES; ANIMALS; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CHOLESTEROL; EXONS; FEMALE; GENE EXPRESSION; GENE TARGETING; INTEGRASES; LIPOPROTEIN LIPASE; MACROPHAGES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; POLY I-C; PREGNANCY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION FACTORS; VIRAL PROTEINS;

ANIMALIA; EUKARYOTA; MUS MUSCULUS; RODENTIA;

EID: 0036205326     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.8.2607-2619.2002     Document Type: Article

References (97)

1. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo
2. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice
3. PPARγ is required for placental, cardiac, and adipose tissue development
4. Transcriptional and post-transcriptional control of apolipoprotein E gene expression in differentiating human monocytes
5. Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages
6. Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes
7. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice
8. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics
9. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
10. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation
11. Activation of PPAR-γ leads to inhibition of anchorage-independent growth of human colorectal cancer cells
12. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
13. Studies in the in vivo expression of the influenza resistance gene Mx by in-situ hybridization
14. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer
15. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
16. A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
17. Identification of two m-PPAR-related receptors and evidence for the existence of five subfamily members
18. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
19. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses
20. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
21. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
22. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages
23. Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function
24. Synthesis and secretion of apoE in thioglycolate-elicited mouse peritoneal macrophages: Effect of cholesterol efflux
25. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
26. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
27. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ
28. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors a and 8
29. 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
30. Cardiac and glycemic benefits of troglitazone treatment in NIDDM
31. Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis
32. ABC1: Connecting yellow tonsils, neuropathy, and very low HDL
33. Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation
34. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes
35. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes
36. The sequence of cDNA encoding lipoprotein lipase. A member of a lipase gene family
37. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells
38. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
39. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
40. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport
41. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux
42. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
43. Ligand for peroxisome proliferatoractivated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
44. Inducible gene targeting in mice
45. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes
46. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage
47. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by highdensity lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages
48. Expression and function of PPARγ in rat and human vascular smooth muscle cells
49. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
50. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
51. An antidiabetic thiazolidinedione is a high-affinity ligand for peroxisome proliferator-activated receptor gamma (PPARγ)
52. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation
53. Macrophages in human atheroma contain PPARγ: Differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro
54. Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3
55. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus
56. The role of PPAR-γ in macrophage differentiation and cholesterol uptake
57. Terminal differentiation of human breast cancer through PPARγ
58. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ
59. The effect of activation of peroxisome proliferator-activated receptor gamma (PPARγ) on human monocyte function: PPARγ ligands do not inhibit tumor necrosis factoralpha release in human monocytic cell line THP-1
60. Inhibition of oxidation of low-density lipoprotein by troglitazone
61. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
62. Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells
63. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages
64. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins
65. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators
66. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
67. The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux
68. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice
69. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability
70. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
71. Expression of the peroxisome proliferator-activated receptor gamma (PPARγ) in human atherosclerosis and regulation in macrophages by colony-stimulating factors and oxidized low-density iipoprotein
72. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants
73. PPAR γ is required for the differentiation of adipose tissue in vivo and in vitro
74. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
75. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
76. Regulation and intracellular trafficking of the ABCA1 transporter
77. Differentiation and reversal of malignant changes in colon cancer through PPARγ
78. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
79. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR
80. Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats
81. Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity
82. PPARγ and the control of adipogenesis
83. Transcriptional activation of the mouse Mx gene by type I interferon
84. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway
85. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
86. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E
87. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
88. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor
89. 15-Deoxy-Δ12, 14-prostaglandin J2 inhibits the β2 integrin-dependent oxidative burst: Involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation
90. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis
91. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
92. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols
93. Cyclopentenone prostaglandins-new allies in the war on inflammation
94. The oxidation hypothesis of atherosclerosis
95. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators
96. Spontaneous hyperchoiesterolemia and arterial lesions in mice lacking apolipoprotein E
97. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors